Zhi Tong Cai Jing·2025-08-12 02:36Core Viewpoint - Spring Medical (01858) has made a strategic investment of 50 million RMB in a healthcare industry fund, which is expected to enhance its core competitiveness and overall profitability [1] Group 1: Investment Details - Spring Medical has invested 50 million RMB in the Nanchang Defu Phase IV Equity Investment Fund, acquiring a 9.2105% share of the fund [1] - The fund primarily targets growth and mature enterprises/projects in the healthcare sector, aligning with the company's main business [1] Group 2: Strategic Implications - The investment is in line with the company's strategic development direction, facilitating its industrial layout [1] - By leveraging the investment experience and resource advantages of its partners, the company aims to integrate industrial operations and capital management, fostering a virtuous cycle of collaborative development [1] - This move is expected to contribute to the company's sustainable, safe, healthy, and stable high-quality growth [1]